Bill & Melinda Gates Foundation has disclosed 6 total holdings in their latest 13F filing with the SEC for the portfolio
date of 2024-06-30. The current portfolio value is calculated to be $60.00 Mil. The turnover rate is 0%.
In Bill & Melinda Gates Foundation's current portfolio as of 2024-06-30, the top 5 holdings are
Immunocore Holdings PLC (IMCR), Vir Biotechnology Inc (VIR), BioNTech SE (BNTX), Exscientia PLC (EXAI), CureVac NV (CVAC), not including call and put options.
Bill & Melinda Gates Foundation did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for Bill & Melinda Gates Foundation, as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at
52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for Bill & Melinda Gates Foundation, which include data from
13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Bill & Melinda Gates Foundation.